Minimum Effective Dose of Ropivacaine for Spinal Anesthesia for Cesarean Delivery

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 31, 2017

Study Completion Date

June 30, 2017

Conditions
Spinal Anesthesia
Interventions
PROCEDURE

Intervertebral space

DRUG

Ropivacaine

The initial dose of ropivacaine is chosen as 12 mg in L2-3 group and 15 mg in L3-4 group with the volume of 3 mL in both groups. The testing interval is 0.5 mg with subsequent doses being determined by the outcome of the previous injection in the same group.If the previous response is ineffective, the next patient will receive 0.5 mg more than the last patient. If the response of the previous patient is effective, the next patient decrease 0.5mg.

Trial Locations (1)

021

Shanghai Sixth People's Hospital, Shanghai

All Listed Sponsors
lead

Shanghai 6th People's Hospital

OTHER

NCT02565303 - Minimum Effective Dose of Ropivacaine for Spinal Anesthesia for Cesarean Delivery | Biotech Hunter | Biotech Hunter